Physician profile
Heidi Lakes
NPI 1205945300
$492.38
in general payments reported to CMS, 2019-2025
16 companies · $17.86 in 2025
The $17.86 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $66.80 · 2023: $21.01 · 2024: $98.00 · 2025: $17.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $110.17 | 2019 | |
| Beta Bionics, INC. | $98.00 | 2024 | Ilet Bionic Pancreas |
| Takeda Pharmaceuticals U.S.A., INC. | $47.48 | 2019 | |
| Novo Nordisk INC | $28.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $25.31 | 2019 | |
| Radius Health, INC. | $24.76 | 2019 | |
| Glaxosmithkline, LLC. | $21.06 | 2020 | |
| Abbvie INC. | $21.01 | 2023 | |
| Exact Sciences Corporation | $17.86 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $16.21 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.19 | 2019 | |
| Merck Sharp & Dohme LLC | $15.82 | 2020 | |
| Lilly USA, LLC | $12.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.53 | 2019 | |
| Astellas Pharma US INC | $12.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Lakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.